Phase II study of carboplatin in previously untreated patients with metastatic small cell lung carcinoma.
Phase II study of carboplatin in previously untreated patients with metastatic small cell lung carcinoma. Cancer Treat Rep. 1987 Mar; 71(3):311-2.